Colostrinin vs DSIP
A neutral, side-by-side comparison of two nootropic & cognitive peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
Colostrinin
Proline-rich polypeptide complex isolated from ovine (sheep) colostrum. Originally researched as an Alzheimer's disease modulator, colostrinin has shown ability to stabilize cognitive function and reduce progression in mild-to-moderate Alzheimer's patients in double-blind trials. Also studied for immune modulation and anti-aging properties via cytokine balance normalization.
Full profileDSIP
DSIP (Delta Sleep Inducing Peptide) is a nonapeptide (9 amino acids) first isolated from rabbit thalamus in 1974, initially believed to directly induce slow-wave (delta) sleep. Research has since broadened its profile considerably: it modulates the HPA axis (reducing stress-driven cortisol), influences GH and LH release, demonstrates antioxidant properties, and may have cardioprotective effects. Despite decades of research, its precise receptor system remains incompletely characterized.
Full profile| Colostrinin | DSIP | |
|---|---|---|
| Category | Nootropic & Cognitive | Nootropic & Cognitive |
| Also known as | PRP (proline-rich polypeptide), ND, colostrum neuropeptide, CLN, ovine proline-rich polypeptide | Delta Sleep Inducing Peptide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu |
| Evidence | Research-stage | Research-stage |
| Dosing range | 100mcg–400mcg mcg, sublingual, on a 3 days on / 3 days off cycle | 100mcg–500mcg mcg, Once daily (evening) or every other day |
| Administration | Sublingual tablet/drop | Subcutaneous injection, Intranasal, Intravenous (clinical studies) |
| Key side effects | Generally well-tolerated, Mild GI discomfort, Rare hypersensitivity (relevant for dairy protein sensitivity), Mild fatigue (initial days) | Generally well-tolerated, Daytime drowsiness if dosed in morning, Mild headache, Altered dream quality (common) |
| Cited sources | 2 references | 3 references |
Key differences
- Administration: Colostrinin — Sublingual tablet/drop; DSIP — Subcutaneous injection, Intranasal, Intravenous (clinical studies).
- Frequency: Colostrinin is typically sublingual, on a 3 days on / 3 days off cycle; DSIP is Once daily (evening) or every other day.
- Research depth: this profile cites 2 sources for Colostrinin vs 3 for DSIP.
How each works
Colostrinin
Colostrinin modulates dendritic cell maturation and shifts cytokine balance toward anti-inflammatory patterns (reduced IL-6, TNF-α; increased IL-10). In neurological models, it reduces amyloid-β aggregation, decreases oxidative stress, and upregulates NGF while modulating the HPA axis stress response. A Polish double-blind trial showed statistically significant cognitive stabilization in mild-to-moderate AD patients over 15 weeks.
DSIP
DSIP does not directly trigger sleep in the simple sense originally proposed — more recent research indicates it modulates the neuroendocrine environment that facilitates sleep. Key findings: it reduces ACTH-driven cortisol elevation under stress, increases GH secretion in some models, and attenuates withdrawal severity in opioid and alcohol dependence (mechanisms unclear). DSIP demonstrates antioxidant effects and has cardioprotective properties in ischemic preconditioning models in animals. Its unique resistance to most peptidases (attributed to its unusual conformation) gives it a relatively long half-life for a nonapeptide.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.